<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported) June 12, 2000
-------------
PerkinElmer, Inc.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Massachusetts 1-5075 04-2052042
--------------- ------------------------ ------------------
(State or other (Commission File Number) (IRS Employer
jurisdiction of Identification No.)
incorporation)
45 William Street, Wellesley, Massachusetts 02481
-------------------------------------------- ---------
(Address of principal executive offices) (Zip Code)
(781) 237-5100
----------------------------------------------------
(Registrant's telephone number, including area code)
Not applicable
-------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE> 2
Item 5. Other Events
On June 12, 2000, PerkinElmer, Inc. (the "Company") announced that it has agreed
to acquire NEN Life Sciences, a provider of state-of-the-art drug discovery
products, services, reagents and technologies to the life science industry, for
approximately $400 million. The transaction, which is subject to customary
closing conditions and regulatory approvals, is anticipated to close early in
the third quarter of 2000. A copy of the press release dated June 12, 2000,
announcing the Company's agreement to acquire NEN Life Sciences is attached to
this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by
reference.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(a) Financial Statements of Business Acquired
Not applicable.
(b) Pro Forma Financial Information
Not applicable.
(c) Exhibits
Exhibit 99.1 - Press release dated June 12, 2000.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PerkinElmer, Inc.
Date: June 21, 2000 By: /s/ Terrance L. Carlson
------------- -----------------------
Senior Vice President
and General Counsel
EXHIBIT INDEX
Exhibit
Number Description
------ -----------
99.1 Press release regarding agreement to acquire NEN Life Sciences
dated June 12, 2000.
